MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Gross Profit 2011-2026 | ZBH
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 5.73 B | 5.66 B | 5.69 B | 5.3 B | 4.2 B | - | 3.34 B | 3.35 B | 3.33 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.73 B | 3.33 B | 4.57 B |
Quarterly Gross Profit Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.29 B | 1.21 B | 654 M | 1.15 B | 1.4 B | 1.21 B | 1.26 B | 1.28 B | 1.34 B | 1.16 B | 1.27 B | 1.29 B | 1.33 B | 1.16 B | 1.27 B | 1.31 B | 1.25 B | 1.19 B | 1.16 B | 1.14 B | 1.1 B | 1.09 B | 840 M | 829 M | 889 M | 790 M | 851 M | 858 M | 900 M | 746 M | 846 M | 846 M | 882 M | 770 M | 843 M | 852 M | 864 M | 780 M | 850 M | 837 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 B | 654 M | 1.04 B |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | USA |
 |
Align Technology
ALGN
|
2.8 B | $ 166.38 | -6.17 % | $ 12.5 B | USA |
 |
Bruker Corporation
BRKR
|
1.65 B | $ 33.72 | -4.58 % | $ 5.02 K | USA |
 |
Alphatec Holdings
ATEC
|
532 M | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 9.07 | -3.41 % | $ 257 M | USA |
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
147 M | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Abbott Laboratories
ABT
|
18.7 B | $ 103.99 | -0.55 % | $ 181 B | USA |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
50 M | $ 24.55 | 0.16 % | $ 208 M | USA |
 |
Boston Scientific Corporation
BSX
|
13.9 B | $ 69.17 | -1.43 % | $ 102 B | USA |
 |
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | USA |
 |
Establishment Labs Holdings
ESTA
|
146 M | $ 55.31 | -7.68 % | $ 1.64 B |  Costa-rica |
 |
CONMED Corporation
CNMD
|
750 M | $ 34.58 | -5.7 % | $ 1.07 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
1.51 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
25.1 M | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
1.36 M | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
61 K | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.99 | -26.67 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
64.3 M | $ 97.36 | -1.4 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 85.33 | -1.73 % | $ 2.96 B | USA |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
48.3 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-147 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
26.9 M | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
942 M | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
779 M | $ 50.13 | -0.54 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
67.1 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | USA |